Dr. Cherian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1145 Olentangy River Rd
Columbus, OH 43212Phone+1 614-293-0066Fax+1 614-293-7264
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2009 - 2012
- University of North DakotaResidency, Internal Medicine, 2003 - 2006
- Christian Medical College VelloreClass of 2000
Certifications & Licensure
- OH State Medical License 2018 - 2025
- IL State Medical License 2018 - 2020
- MO State Medical License 2009 - 2019
- ND State Medical License 2003 - 2009
- MN State Medical License 2006 - 2008
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Paul Calabresi NIH K12 Oncology Award 2016
- American Society of Hematology Research Training Award for Fellows 2012
Clinical Trials
- Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation Start of enrollment: 2023 Oct 31
Roles: Contact
Publications & Presentations
PubMed
- 5 citationsTyphoid vaccine does not impact feelings of social connection or social behavior in a randomized crossover trial among middle-aged female breast cancer survivors.Annelise A Madison, Baldwin Way, Kyle G Ratner, Megan Renna, Rebecca Andridge
Brain, Behavior, and Immunity. 2023-01-01 - 2 citationsAugmentation of Extracellular ATP Synergizes With Chemotherapy in Triple Negative Breast Cancer.Jasmine M Manouchehri, Jharna Datta, Natalie Willingham, Robert Wesolowski, Daniel Stover
Frontiers in Oncology. 2022-01-01 - 59 citationsEstrogen Receptor Beta (ERβ): A Ligand Activated Tumor Suppressor.Rahul Mal, Alexa Magner, Joel David, Jharna Datta, Meghna Vallabhaneni
Frontiers in Oncology. 2020-10-23
Journal Articles
- An Activating Mutation of Interferon Regulatory Factor 4 (IRF4) in Adult T Cell LeukemiaCherian MA, Olson S, Sundaramoorthi H, Cates K, Cheng X, Harding J, Martens A, Challen GA, Tyagi M, Ratner L, Rauch D, J Biol Chem, 1/14/2018
- The Role of Neratinib in HER2 Driven Breast CancerCherian MA, Ma CX, Future Oncol, 1/20/2017
- A study of high-dose lenalidomide induction and low-dose lenalidomide maintenance therapy for patients with hypomethylating agent refractory myelodysplastic syndromeCherian MA, Tibes R, Gao F, Fletcher T, Fiala M, Uy GL, Westervelt P, Jacoby MA, Cashen AF, Stockerl-Goldstein K, DiPersio JF, Vij R, Leuk Lymphoma, 1/1/2016
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: